Neuphoria To Look At Strategic Options After BNC210 Fails In Social Anxiety

Vistagen’s Fasedienol Now In Lead For Social Anxiety

(Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D